<qa>  What is a phase 1 randomized, double-blind, placebo controlled study to evaluateThis is a phase 1, randomized, double-blind, placebo-controlled study to evaluate the safety and tolerability of REGN1193 in patients with Type 2 Diabetes Mellitus. 